Physician profile
Eileen Wheeler
NPI 1881692945
$7,720.97
in general payments reported to CMS, 2019-2025
52 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,576 · 2020: $1,267 · 2021: $1,997 · 2022: $1,913 · 2023: $968.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $968.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $967.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,073.84 | 2019-2023 | Ozempic |
| Abbvie INC. | $860.64 | 2021-2023 | Vraylar, Ubrelvy, Rinvoq |
| Amgen INC. | $846.57 | 2019-2023 | Otezla, Repatha |
| Lilly USA, LLC | $428.22 | 2019-2023 | Mounjaro, Jardiance, Emgality |
| Astrazeneca Pharmaceuticals Lp | $374.40 | 2019-2022 | |
| Allergan, INC. | $360.66 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $337.79 | 2021-2023 | Rexulti |
| Janssen Pharmaceuticals, INC | $293.26 | 2019-2022 | |
| Pfizer INC. | $217.01 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $205.78 | 2019-2023 | Dificid |
| Astellas Pharma US INC | $196.79 | 2019-2021 | |
| Paratek Pharmaceuticals, INC. | $190.48 | 2021-2022 | |
| Amarin Pharma, INC. | $189.95 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $171.70 | 2022 | |
| Novartis Pharmaceuticals Corporation | $149.45 | 2019-2023 |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eileen Wheeler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.